Outcome of 52nd Annual General Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aspira Pathlab & Diagnostics held its 52nd AGM on September 26, 2025, via video conferencing, lasting about 27 minutes. Chairman Dr. Haseeb Drabu shared that the company turned profitable with a net profit of INR 2.07 crores in FY25, compared to a net loss of INR 2.60 crores in the previous year. The company added 91 new locations during FY25, expanding its footprint to 600+ centres across India, and hinted at upcoming deals in the pipeline that could trigger a growth phase. Four resolutions were passed: adoption of FY25 financial statements, reappointment of Executive Director Nikunj V. Mange (retiring by rotation), appointment of M/s. Nilesh A. Pradhan & Co., LLP as Secretarial Auditors for five years, and appointment of Dr. Alaka Keshav Deshpande as Independent Director for three years.
The swing from loss to profit and significant network expansion (91 new centres, 600+ total) signals improving business momentum, which is positive for shareholders. New deals in the pipeline and board continuity/reinforcement could support future growth, though investors should watch for the detailed voting results and any updates on the pipeline deals.